6 - 19 June 2021, Salzburg Faculty
Professor David Zarski Project Finance Professor Zarski is a member of Schuyler Roche Crisham in Chicago, Illinois. In addition to managing $25-billion-plus transactions, he has served as counsel to a wholly owned bank subsidiary of a major retailer in a public offering of a credit card receivable securitization exceeding $1-billion. He has served as principal structuring counsel to the United States branch of a large global bank and its associated commercial paper conduits in various transactions. He holds a Juris Doctor degree from DePaul University and is a member of the Illinois Bar.
Professor Joseph Hetrick Crossborder Litigation Professor Hetrick is a former partner at Dechert LLP. He defended Philip Morris in tobacco litigation and represented Baxter Healthcare in mass tort litigation throughout the world. He was part of Dechert’s national defense team representing GlaxoSmithKline in the Baycol litigation and worked in the Paxil litigation in New Jersey and Pennsylvania. He played a central role in litigation related to a painkiller for Merck & Co. and served as trial counsel for Wyeth in the fen-phen litigation and dealt with product liability matters for West Pharmaceutical, York International Corporation, Stryker Corporation, and Airgas, Inc. He holds a law degree from Temple University and is a member of the Pennsylvania Bar.
6 - 19 June 2021, Salzburg Faculty
Project Finance - P rofessor David Zarski Professor Zarski is a member of Schuyler Roche Crisham in Chicago, Illinois. In addition to managing $25-billion-plus transactions, he has served as counsel to a wholly owned bank subsidiary of a major retailer in a public offering of a credit card receivable securitization exceeding $1-billion. He has served as principal structuring counsel to the United States branch of a large global bank and its associated commercial paper conduits in various transactions. He holds a Juris Doctor degree from DePaul University and is a member of the Illinois Bar.
Crossborder Litigation - Professor Joseph Hetrick Professor Hetrick is a former partner at Dechert LLP. He defended Philip Morris in tobacco litigation and represented Baxter Healthcare in mass tort litigation throughout the world. He was part of Dechert’s national defense team representing GlaxoSmithKline in the Baycol litigation and worked in the Paxil litigation in New Jersey and Pennsylvania. He played a central role in litigation related to a painkiller for Merck & Co. and served as trial counsel for Wyeth in the fen-phen litigation and dealt with product liability matters for West Pharmaceutical, York International Corporation, Stryker Corporation, and Airgas, Inc. He holds a law degree from Temple University and is a member of the Pennsylvania Bar.